IBDEI1K9 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28046,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28046,1,2,0)
 ;;=2^V58.64
 ;;^UTILITY(U,$J,358.3,28046,1,5,0)
 ;;=5^L/T (Current) NSAIDS Use
 ;;^UTILITY(U,$J,358.3,28046,2)
 ;;=^329979
 ;;^UTILITY(U,$J,358.3,28047,0)
 ;;=V58.65^^172^1779^30
 ;;^UTILITY(U,$J,358.3,28047,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28047,1,2,0)
 ;;=2^V58.65
 ;;^UTILITY(U,$J,358.3,28047,1,5,0)
 ;;=5^L/T (Current) Steroids Use
 ;;^UTILITY(U,$J,358.3,28047,2)
 ;;=^329980
 ;;^UTILITY(U,$J,358.3,28048,0)
 ;;=V58.66^^172^1779^25
 ;;^UTILITY(U,$J,358.3,28048,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28048,1,2,0)
 ;;=2^V58.66
 ;;^UTILITY(U,$J,358.3,28048,1,5,0)
 ;;=5^L/T (Current) Aspirin Use
 ;;^UTILITY(U,$J,358.3,28048,2)
 ;;=^331584
 ;;^UTILITY(U,$J,358.3,28049,0)
 ;;=V58.67^^172^1779^27
 ;;^UTILITY(U,$J,358.3,28049,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28049,1,2,0)
 ;;=2^V58.67
 ;;^UTILITY(U,$J,358.3,28049,1,5,0)
 ;;=5^L/T (Current) Insulin Use
 ;;^UTILITY(U,$J,358.3,28049,2)
 ;;=^331585
 ;;^UTILITY(U,$J,358.3,28050,0)
 ;;=V58.68^^172^1779^26
 ;;^UTILITY(U,$J,358.3,28050,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28050,1,2,0)
 ;;=2^V58.68
 ;;^UTILITY(U,$J,358.3,28050,1,5,0)
 ;;=5^L/T (Current) Bisphos Use
 ;;^UTILITY(U,$J,358.3,28050,2)
 ;;=^340624
 ;;^UTILITY(U,$J,358.3,28051,0)
 ;;=V58.69^^172^1779^29
 ;;^UTILITY(U,$J,358.3,28051,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28051,1,2,0)
 ;;=2^V58.69
 ;;^UTILITY(U,$J,358.3,28051,1,5,0)
 ;;=5^L/T (Current) Other Meds Use
 ;;^UTILITY(U,$J,358.3,28051,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,28052,0)
 ;;=V58.83^^172^1779^50
 ;;^UTILITY(U,$J,358.3,28052,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28052,1,2,0)
 ;;=2^V58.83
 ;;^UTILITY(U,$J,358.3,28052,1,5,0)
 ;;=5^Therapeutic Drug Monitoring
 ;;^UTILITY(U,$J,358.3,28052,2)
 ;;=^322076
 ;;^UTILITY(U,$J,358.3,28053,0)
 ;;=V62.5^^172^1779^32
 ;;^UTILITY(U,$J,358.3,28053,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28053,1,2,0)
 ;;=2^V62.5
 ;;^UTILITY(U,$J,358.3,28053,1,5,0)
 ;;=5^Legal Circumstances
 ;;^UTILITY(U,$J,358.3,28053,2)
 ;;=^175799
 ;;^UTILITY(U,$J,358.3,28054,0)
 ;;=V79.1^^172^1780^1
 ;;^UTILITY(U,$J,358.3,28054,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28054,1,2,0)
 ;;=2^V79.1
 ;;^UTILITY(U,$J,358.3,28054,1,5,0)
 ;;=5^Alcohol Screen
 ;;^UTILITY(U,$J,358.3,28054,2)
 ;;=^295678
 ;;^UTILITY(U,$J,358.3,28055,0)
 ;;=V61.21^^172^1780^8
 ;;^UTILITY(U,$J,358.3,28055,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28055,1,2,0)
 ;;=2^V61.21
 ;;^UTILITY(U,$J,358.3,28055,1,5,0)
 ;;=5^Victim Child Abuse Counseling
 ;;^UTILITY(U,$J,358.3,28055,2)
 ;;=^304301
 ;;^UTILITY(U,$J,358.3,28056,0)
 ;;=V65.40^^172^1780^2
 ;;^UTILITY(U,$J,358.3,28056,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28056,1,2,0)
 ;;=2^V65.40
 ;;^UTILITY(U,$J,358.3,28056,1,5,0)
 ;;=5^Counseling NOS
 ;;^UTILITY(U,$J,358.3,28056,2)
 ;;=^87449
 ;;^UTILITY(U,$J,358.3,28057,0)
 ;;=V65.42^^172^1780^7
 ;;^UTILITY(U,$J,358.3,28057,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28057,1,2,0)
 ;;=2^V65.42
 ;;^UTILITY(U,$J,358.3,28057,1,5,0)
 ;;=5^Substance Use/Abuse Counseling
 ;;^UTILITY(U,$J,358.3,28057,2)
 ;;=^303467
 ;;^UTILITY(U,$J,358.3,28058,0)
 ;;=V65.44^^172^1780^3
 ;;^UTILITY(U,$J,358.3,28058,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28058,1,2,0)
 ;;=2^V65.44
 ;;^UTILITY(U,$J,358.3,28058,1,5,0)
 ;;=5^HIV Counseling
 ;;^UTILITY(U,$J,358.3,28058,2)
 ;;=^303469
 ;;^UTILITY(U,$J,358.3,28059,0)
 ;;=V65.49^^172^1780^5
 ;;^UTILITY(U,$J,358.3,28059,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28059,1,2,0)
 ;;=2^V65.49
 ;;^UTILITY(U,$J,358.3,28059,1,5,0)
 ;;=5^Oth Specified Counseling
